Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

TechMARK movers: Restructuring costs hit Sinclair figures

Thu, 25th Feb 2010 14:36
Sinclair Pharma shares fell after it reported a slump into loss in 2009 but much of that was due to restructuring costs. However, another large loss is expected this year. New chief executive Chris Spooner has wasted little time in restructuring the business and boosting the sales expertise in the group. He ended Sinclair's distribution agreement with Orapharma Inc for Decapinol mouth rinse and plans to find another partner covering more of the market.Sinclair has negotiated new debt facilities of Β£9m and raised Β£18.2m from a share placing. The cash was used to finance the acquisition of Flammazine and Flammacerium (used for topical treatment of burns) from Solvay Pharmaceuticals for Β£16.8m. Sinclair had net debt of Β£12.3m at the end of 2009.Revenues were one-third lower than last year at Β£11m. Stripping out one-off payments, underlying revenues were 1% lower. Sinclair made a profit of Β£3.17m in 2008 but that was down to foreign exchange gains. The 2009 loss was Β£14.5m and around two-thirds of this was due to impairment charges and restructuring costs. Broker Singer has increased its forecast loss for 2010 from Β£6.1m to Β£15m. Stripping out exceptional charges the forecast loss rises from Β£1.7m to Β£2m. Singer has a 41p a share price target and says it believes that "the company is now better placed to deliver long term financial growth". Shares in IT services provider Logica are recovering following yesterday's fall on the announcement of figures for 2009. Revenues are expected to fall in the first half of 2010 and be flat for the year as a whole. FTSE TechMARK - RisersVisonic (VSC) 82.00p +2.50%Psion (PON) 92.00p +2.22%Ark Therapeutics (AKT) 14.50p +1.75%NXT (NTX) 14.75p +1.72%BT Group (BT.A) 117.60p +1.29%Intec Telecom Systems (ITL) 98.00p +1.29%COLT Telecom Group S.A. (COLT) 136.50p +1.11%Logica (LOG) 118.20p +1.11%Vodafone Group (VOD) 142.20p +0.85%Anite Group (AIE) 32.50p +0.78%FTSE TechMARK - FallersRenovo Group (RNVO) 27.25p -6.03%Sinclair Pharma (SPH) 29.50p -4.84%Oxford Instruments (OXIG) 232.00p -4.13%Gresham Computing (GHT) 19.00p -3.80%Vernalis (VER) 73.50p -3.61%Morse (MOR) 40.00p -2.44%Phoenix IT Group (PNX) 275.00p -2.22%Innovation Group (TIG) 12.50p -1.96%XP Power (XPP) 425.00p -1.96%Consort Medical (CSRT) 356.00p -1.79%

Related News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Sinclair Pharma News

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Exec Buys More Shares
6 May 2014

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Exec Buys More Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said Non-Executive Director Stuart Swanson bought 900,000 shares at 30.6214 pence each Friday....

Sinclair IS Pharma non-execs subscribe for placing shares
2 May 2014

Sinclair IS Pharma non-execs subscribe for placing shares

Stuart Swanson, a non-executive director of AIM-listed Sinclair IS Pharma on Friday subscribed for just under 3.13m shares as part of a placing that w...

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys More Shares
2 May 2014

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys More Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Friday said Non-Executive Director Stuart Swanson bought 320,226 shares at 30.6719 pence each Thursday...

Sinclair IS Pharma CEO grows stake to 8.75m shares
1 May 2014

Sinclair IS Pharma CEO grows stake to 8.75m shares

The Chief Executive Officer (CEO) of AIM-listed Sinclair IS Pharma this week added 285,844 to his stake, while fellow board member Stuart Swanson made...

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys More Shares
1 May 2014

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys More Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Thursday said Non-Executive Director Stuart Swanson bought 12,774 shares at 30.5 pence each Wednesday....

UK MORNING BRIEFING: Shares Higher; Lloyds And BG Group Profits Down
1 May 2014

UK MORNING BRIEFING: Shares Higher; Lloyds And BG Group Profits Down

LONDON (Alliance News) - UK shares have opened higher Thursday amid holidays across Asia and Europe. The US Federal Reserve late Wednesday continued t...

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys Shares
30 Apr 2014

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Executive Buys Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Wednesday said Non-Executive Director Stuart Swanson bought 154,225 shares at 30.75 pence each Tuesday...